During the past decade, Universitätsklinikum Ulm, Klinik für Neurologie conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 9 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Ulm, Klinik für Neurologie" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Charite University, Berlin, Germany" with 4 trials sponsored, "CENTOGENE GmbH Rostock" with 3 trials sponsored, "Cytokinetics" with 2 trials sponsored and "D-Pharm Ltd." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Ulm, Klinik für Neurologie" #1 collaborator was "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Julius Clinical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Ulm, Klinik für Neurologie" are "Alzheimer's Disease" (5 trials), "Amyotrophic Lateral Sclerosis" (3 trials), "Cerebrovascular Accident" (3 trials), "Huntington Disease" (3 trials) and "Huntington's Disease" (3 trials). Many other conditions were trialed in "Universitätsklinikum Ulm, Klinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Ulm, Klinik für Neurologie" are "Drug" (26 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Gantenerumab" (4 trials), "Ocrelizumab" (3 trials), "Antihistamine" (2 trials) and "Arimoclomol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Ulm, Klinik für Neurologie" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Ulm, Klinik für Neurologie". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Universitätsklinikum Ulm, Klinik für Neurologie, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Ulm, Klinik für Neurologie, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".